Biblio Discovery — Demo Discovery Service

9 hasil untuk "Francesca Lessi"

Menampilkan 1–9 · 1,56 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Down-Regulation of Serum/Glucocorticoid Regulated Kinase 1 in Colorectal Tumours Is Largely Independent of Promoter Hypermethylation

    Francesca Lessi; Andrew Beggs; Mariagrazia de Palo dkk.

    PLoS ONE, Vol. 5 No. 11 · 2010 · Inggris · PLOS Scopus

    Background: We have previously shown that serum/glucocorticoid regulated kinase 1 (SGK1) is down-regulated in colorectal cancers (CRC) with respect to normal tissue. As hyper-methylation of promoter regions is a well-known mechanism of gene silencing in cancer, we tested whether the SGK1 promoter…

  2. Artikel Jurnal Teks lengkap

    Mouse mammary tumour virus-like env nucleotide and p14 signal peptide are present in feline mammary carcinomas, but not in neoplastic or dysplastic canine mammary lesions

    Prospero Civita; Michele Menicagli; Claudia Scopelliti dkk.

    PLOS ONE, Vol. 13 No. 7 · 2018 · Inggris · PLOS Scopus

    Mouse mammary tumour virus-like (MMTV-like) is suspected to be involved in human breast cancer and it has been hypothesized that companion animals might have a role in viral transmission. The aim of our study was to investigate the presence of MMTV-like nucleotide sequences and viral protein in a…

    Juga tersedia di: DOAJ

  3. Artikel Jurnal Teks lengkap

    Loss of c-KIT expression in thyroid cancer cells

    Sara Franceschi; Francesca Lessi; Federica Panebianco dkk.

    PLOS ONE, Vol. 12 No. 3 · 2017 · Inggris · PLOS Scopus

    Papillary thyroid carcinoma is the most frequent histologic type of thyroid tumor. Few studies investigated the role of c-KIT expression in thyroid tumors, suggesting a role for this receptor and its ligand in differentiation and growth control of thyroid epithelium and a receptor loss following…

    Juga tersedia di: DOAJ

  4. Artikel Jurnal Teks lengkap

    Molecular characterization of low grade and high grade bladder cancer

    Alessandro Apollo; Valerio Ortenzi; Cristian Scatena dkk.

    PLOS ONE, Vol. 14 No. 1 · 2019 · Inggris · PLOS Scopus

    Background: Bladder cancer (BC) is the 9th most common cancer diagnosis worldwide. Low grade (LG) represents 70% of all BCs, characterized by recurrence and rare ability (10–15%) to progress to high grade (HG) and invade. The remaining 30% is high grade (HG), fast invasive BC, which is resistant to…

  5. Artikel Jurnal Teks lengkap

    Single-Cell Molecular Characterization to Partition the Human Glioblastoma Tumor Microenvironment Genetic Background

    Francesca Lessi; Sara Franceschi; Mariangela Morelli dkk.

    Cells, Vol. 11 No. 7 · 2022 · Inggris · DOAJ Scopus

    Background: Glioblastoma (GB) is a devastating primary brain malignancy. The recurrence of GB is inevitable despite the standard treatment of surgery, chemotherapy, and radiation, and the median survival is limited to around 15 months. The barriers to treatment include the complex interactions…

  6. Artikel Jurnal Teks lengkap

    Pathological Features and Molecular Phenotype of MMTV Like-Positive Feline Mammary Carcinomas

    Francesca Parisi; Luisa Vera Muscatello; Prospero Civita dkk.

    Animals, Vol. 11 No. 10 · 2021 · Inggris · DOAJ Scopus

    In the last few years MMTV-like nucleotide sequences were detected in some feline and canine mammary tumours. Due to the confirmed role of cats in the epidemiology of the MMTV-like virus, the aim of this study was to investigate the main pathological features of positive feline mammary carcinomas…

  7. Artikel Jurnal Teks lengkap

    Exploring Regorafenib Responsiveness and Uncovering Molecular Mechanisms in Recurrent Glioblastoma Tumors through Longitudinal In Vitro Sampling

    Mariangela Morelli; Francesca Lessi; Sara Franceschi dkk.

    Cells, Vol. 13 No. 6 · 2024 · Inggris · DOAJ Scopus

    Glioblastoma, a deadly brain tumor, shows limited response to standard therapies like temozolomide (TMZ). Recent findings from the REGOMA trial underscore a significant survival improvement offered by Regorafenib (REGO) in recurrent glioblastoma. Our study aimed to propose a 3D ex vivo drug…